103 related articles for article (PubMed ID: 20643786)
1. The novel Hsp90 inhibitor NXD30001 induces tumor regression in a genetically engineered mouse model of glioblastoma multiforme.
Zhu H; Woolfenden S; Bronson RT; Jaffer ZM; Barluenga S; Winssinger N; Rubenstein AE; Chen R; Charest A
Mol Cancer Ther; 2010 Sep; 9(9):2618-26. PubMed ID: 20643786
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of EGFR induces a c-MET-driven stem cell population in glioblastoma.
Jun HJ; Bronson RT; Charest A
Stem Cells; 2014 Feb; 32(2):338-48. PubMed ID: 24115218
[TBL] [Abstract][Full Text] [Related]
3. Small-Molecule HSP27 Inhibitor Abolishes Androgen Receptors in Glioblastoma.
Li Y; Orahoske CM; Geldenhuys WJ; Bhattarai A; Sabbagh A; Bobba V; Salem FM; Zhang W; Shukla GC; Lathia JD; Wang B; Su B
J Med Chem; 2021 Feb; 64(3):1570-1583. PubMed ID: 33523674
[TBL] [Abstract][Full Text] [Related]
4. Exploring ncRNA-mediated regulation of EGFR signalling in glioblastoma: From mechanisms to therapeutics.
Thapa R; Afzal M; Goyal A; Gupta G; Bhat AA; Almalki WH; Kazmi I; Alzarea SI; Shahwan M; Kukreti N; Ali H; Dureja H; Kumar P; Singh TG; Kuppusamy G; Singh SK; Dua K
Life Sci; 2024 May; 345():122613. PubMed ID: 38582393
[TBL] [Abstract][Full Text] [Related]
5. Lead Optimization of Androgen Receptor-HSP27 Disrupting Agents in Glioblastoma.
Li Y; Orahoske C; Salem F; Johnson A; Tannous C; Devole L; Zhang W; Lathia JD; Wang B; Su B
J Med Chem; 2023 Apr; 66(8):5567-5583. PubMed ID: 37023333
[TBL] [Abstract][Full Text] [Related]
6. Monocyte depletion enhances neutrophil influx and proneural to mesenchymal transition in glioblastoma.
Chen Z; Soni N; Pinero G; Giotti B; Eddins DJ; Lindblad KE; Ross JL; Puigdelloses Vallcorba M; Joshi T; Angione A; Thomason W; Keane A; Tsankova NM; Gutmann DH; Lira SA; Lujambio A; Ghosn EEB; Tsankov AM; Hambardzumyan D
Nat Commun; 2023 Apr; 14(1):1839. PubMed ID: 37012245
[TBL] [Abstract][Full Text] [Related]
7. In silico studies on marine actinomycetes as potential inhibitors for Glioblastoma multiforme.
Kirubakaran P; Kothapalli R; Singh KhD; Nagamani S; Arjunan S; Muthusamy K
Bioinformation; 2011 Apr; 6(3):100-6. PubMed ID: 21584184
[TBL] [Abstract][Full Text] [Related]
8. The soft underbelly of tumor cells.
Shi Y; Lim SK; Parada LF
Cell Res; 2014 Aug; 24(8):910-1. PubMed ID: 24874955
[TBL] [Abstract][Full Text] [Related]
9. A novel small molecule HSP90 inhibitor, NXD30001, differentially induces heat shock proteins in nervous tissue in culture and in vivo.
Cha JR; St Louis KJ; Tradewell ML; Gentil BJ; Minotti S; Jaffer ZM; Chen R; Rubenstein AE; Durham HD
Cell Stress Chaperones; 2014 May; 19(3):421-35. PubMed ID: 24092395
[TBL] [Abstract][Full Text] [Related]
10. Altered chromatin architecture underlies progressive impairment of the heat shock response in mouse models of Huntington disease.
Labbadia J; Cunliffe H; Weiss A; Katsyuba E; Sathasivam K; Seredenina T; Woodman B; Moussaoui S; Frentzel S; Luthi-Carter R; Paganetti P; Bates GP
J Clin Invest; 2011 Aug; 121(8):3306-19. PubMed ID: 21785217
[TBL] [Abstract][Full Text] [Related]
11. Targeting Heat Shock Proteins in Malignant Brain Tumors: From Basic Research to Clinical Trials.
Babi A; Menlibayeva K; Bex T; Doskaliev A; Akshulakov S; Shevtsov M
Cancers (Basel); 2022 Nov; 14(21):. PubMed ID: 36358853
[TBL] [Abstract][Full Text] [Related]
12. Mouse models of glioblastoma for the evaluation of novel therapeutic strategies.
Haddad AF; Young JS; Amara D; Berger MS; Raleigh DR; Aghi MK; Butowski NA
Neurooncol Adv; 2021; 3(1):vdab100. PubMed ID: 34466804
[TBL] [Abstract][Full Text] [Related]
13. Transferrin Modified GSH Sensitive Hyaluronic Acid Derivative Micelle to Deliver HSP90 Inhibitors to Enhance the Therapeutic Efficacy of Brain Cancers.
Debele TA; Wu PC; Wei YF; Chuang JY; Chang KY; Tsai JH; Su WP
Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34069106
[TBL] [Abstract][Full Text] [Related]
14. A Brain-Penetrating Hsp90 Inhibitor NXD30001 Inhibits Glioblastoma as a Monotherapy or in Combination With Radiation.
Chen H; Gong Y; Ma Y; Thompson RC; Wang J; Cheng Z; Xue L
Front Pharmacol; 2020; 11():974. PubMed ID: 32695001
[TBL] [Abstract][Full Text] [Related]
15. Photothermal therapy of glioblastoma multiforme using multiwalled carbon nanotubes optimized for diffusion in extracellular space.
Eldridge BN; Bernish BW; Fahrenholtz CD; Singh R
ACS Biomater Sci Eng; 2016 Jun; 2(6):963-976. PubMed ID: 27795996
[TBL] [Abstract][Full Text] [Related]
16. A CNS-permeable Hsp90 inhibitor rescues synaptic dysfunction and memory loss in APP-overexpressing Alzheimer's mouse model via an HSF1-mediated mechanism.
Wang B; Liu Y; Huang L; Chen J; Li JJ; Wang R; Kim E; Chen Y; Justicia C; Sakata K; Chen H; Planas A; Ostrom RS; Li W; Yang G; McDonald MP; Chen R; Heck DH; Liao FF
Mol Psychiatry; 2017 Jul; 22(7):990-1001. PubMed ID: 27457810
[TBL] [Abstract][Full Text] [Related]
17. Advances in HSP27 and HSP90-targeting strategies for glioblastoma.
van Ommeren R; Staudt MD; Xu H; Hebb MO
J Neurooncol; 2016 Apr; 127(2):209-19. PubMed ID: 26842818
[TBL] [Abstract][Full Text] [Related]
18. Contemporary murine models in preclinical astrocytoma drug development.
McNeill RS; Vitucci M; Wu J; Miller CR
Neuro Oncol; 2015 Jan; 17(1):12-28. PubMed ID: 25246428
[TBL] [Abstract][Full Text] [Related]
19. Getting folded: chaperone proteins in muscle development, maintenance and disease.
Smith DA; Carland CR; Guo Y; Bernstein SI
Anat Rec (Hoboken); 2014 Sep; 297(9):1637-49. PubMed ID: 25125177
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
